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Saudi SCD patients’ symptoms and quality
of life relative to the number of ED visits
Anwar E. Ahmed1,2*, Ahmed S. Alaskar1,2,3, Donna K. McClish4, Yosra Z. Ali3, Mohammed H. Aldughither5,
Ahmad M. Al-Suliman6 and Hafiz M. Malhan7

Abstract
Background: Individuals living with sickle cell disease (SCD) have significantly increased emergency department
(ED) use compared to the general population. In Saudi Arabia, health care is free for all individuals and therefore
has no bearing on increased ED visits. However, little is known about the relationship between quality of life (QoL)
and frequency of acute care utilization in this patient population.
Methods: A cross-sectional study was conducted on 366 patients with SCD who attended the outpatient
department at King Fahad Hospital, Hofuf, Saudi Arabia. Data were collected through self-administered surveys,
which included: demographics, SCD-related ED visits, clinical issues, and QoL levels. We assessed the ED use by
asking for the number of SCD-related ED visits within a 6-month period.
Results: The self-report survey of ED visits was completed by 308 SCD patients. The median number of SCD-related
ED visits within a 6-month time period (IQR) was four (2-7 visits). According to the unadjusted negative binomial
model, the rate of SCD-related ED visits increased by (46, 39.3, 40, and 53.5 %) for patients with fever, skin redness
with itching, swelling, and blood transfusion, respectively. Poor QoL tends to increase the rate of SCD-related ED
visits. Well education and poor general health positively influenced the rate of SCD-related ED visits. Well education
tends to increase the rate of SCD-related ED visits by 50.2 %. The rate of SCD-related ED visits decreased by 1.4 %
for every point increase in general health.
Conclusion: Saudi patients with sickle cell disease reported a wide range of SCD-related ED visits. It was estimated
that six of 10 SCD patients had at least three ED visits within a 6-month period. Well education and poor general
health resulted in an increase in the rate of SCD-related ED visits.
Keywords: Sickle cell disease, Emergency department visits, Pain, Inherited anemia, Quality of life
Abbreviations: ED, Emergency department; HRQoL, Health-related quality of life; QoL, Quality of life; SCD, Sickle
cell disease; SF-36, 36-Item Short Form Health Survey

Background
Sickle cell disease (SCD) is comprised of a group of
inherited red blood cell disorders characterized by the
presence of abnormal hemoglobin. SCD is present
throughout Saudi Arabia, mostly in the eastern and
southern provinces. Information about the prevalence of
SCD in Saudi Arabia is not well established, but studies
* Correspondence: ahmeda5@vcu.edu; ahmedan@ngha.med.sa
1
King Saud bin Abdulaziz University for Health Sciences, College of Public
Health and Health Informatics, MC 2350, P.O.Box 22490, Riyadh 11426, KSA,
Saudi Arabia
2
King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
Full list of author information is available at the end of the article

to date have reported that SCD is a relatively common
genetic disorder in this part of the world [1–3].
The clinical manifestations of SCD often lead the patient
to visit the emergency department [4–8]. The most common manifestation of SCD is vaso-occlusive crisis, which
can cause a multitude of major organ complications as well
as result in recurrent painful episodes [7, 9–14]. This
increases the risks for infections and other health complications that require emergency intervention [15–17]. In
particular, high rates of ED utilization have been reported
in single and multi-institutional studies [4, 6, 7, 11, 18–24].
The predictors of frequent ED utilization are not fully
understood [20], but the following variables have been
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found to be associated with higher ED and hospital
utilization: (1) the more severe disease and disease-related
complications, (2) the need for pain crisis management
[25], (3) higher white blood cell counts, (4) lower
hemoglobin levels, (5) asthma, (6) being publically insured,
(7) being 18 to 30 years old, and (8) the inability to obtain
follow-up appointments with hematology. Within these
presentations, pain is the most common complication of
SCD requiring ED visits and hospitalization.
Our patients with SCD receive healthcare by routinely
visiting primary care physicians for health checkups, managing pain, and urine/blood tests. Many of these patients
do not have an assigned hematologist to provide counseling
or advice on pain management. However, primary care
physicians may make referrals to the Hematology Outpatient Clinic where necessary. Although healthcare is free
to all individuals in Saudi Arabia, it is unknown whether
all affected patients have access to a disease specialist.
Because the health system in Saudi Arabia provides
free access to the Saudi population, patients with SCD
have access not only to specialized health care but also
to home pain medications. This includes over-thecounter pain medications such as Advil, Tylenol, etc. to
control mild pain at home. Saudi SCD patients may have
opioid pain medication available at home upon doctor
prescription. At the ED, patients may request prescriptions for stronger medicines such as opioid medications,
including morphine, tramadol, hydrocodone, methadone,
fentanyl, codeine, and meperidine. However, as is the
case with any chronic disease, patient compliance continues to be an important issue.
Self-report measurements of pain and wellbeing as measured by the 36-Item Short Form Health Survey (SF-36)
may predict frequent ED visits in patients with SCD. Increased life expectancy due to recent medical advances
has increased the need to understand more fully the
health-related quality of life (HRQoL) [26] in patients with
SCD [2]. Previous research has indicated that patients
with SCD experience a lower HRQoL [1, 2, 25, 27–33]
compared to the general adult population. A number of
disease-related factors have been found to affect HRQoL
in patients with SCD. These can develop into lifethreatening complications as well as extensive organ
damage, reducing both quality of life (QoL) and life
expectancy. A clinically important reduction in the HRQoL
and the presence of other prognostic factors can further
contribute to determining the reasons for ED visits [34].
The presence of complications and risk factors may
also raise the risk level of ED visits in patients with SCD,
such as swelling in the hands or feet, fever, blood transfusion, and family history of anemia. The current investigation studied a sample of SCD patients from Saudi
Arabia to assess the frequency of ED use and its relation
to patients’ symptoms and QoL.
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Methods
This was a cross-sectional study of patients with SCD who
attended the outpatient clinic of a local hospital in Saudi
Arabia from October 1, 2014 to February 29, 2015. Participants of the study were adult patients with SCD who were
treated in the Inherited Blood Disorder Center, King
Fahad Hospital (KFH) - Hofuf, Eastern Region, Saudi
Arabia. KFH - Hofuf is the main hospital in the Al-Ahsa
region in eastern Saudi Arabia. Serving about one and a
half million people from the general population of AlAhsa, it receives cases from Al-Ahsa region health centers
and government and private hospitals.
The study population was composed of SCD patients
who were attending for a follow-up visit to the
Hematology Outpatient Clinic. This study was approved
by the Ministry of Health, Kingdom of Saudi Arabia (IRB
Log No. 15-247E) and King Abdullah International Medical
Research Center, Research Protocol - RC12/127/R. The
study conducted an anonymous survey of patients with
SCD, and no identifiable data were collected from the patients. Only patients who agreed to participate in the study
were asked to complete and return the survey.
Patients’ characteristics—such as age, gender, frequency
of ED visits, marital status, employment, and education
level—were collected. The following clinical characteristics were assessed: duration of illness, obesity, chronic
disease other than SCD, and whether the patient had a
history of inherited anemia and a history of blood transfusion. Complications and symptoms of SCD within the past
6 months were assessed through self-report, such as fever
and swelling of the hands or feet. Since skin redness with
itching can be a result of infections or side effects from
certain SCD medications, and skin redness with itching
can be a potential indicator of poor QoL, the study collected data on this characteristic as well. We evaluated the
frequency of ED visits by asking for the number of SCDrelated ED visits within the past six months. A validated
and Arabic-translated RAND-36 measure of healthrelated quality of life (HRQoL) questionnaire [35] was also
administered to the study participants. Patients rated their
HRQoL in terms of their feelings and perceptions with regard to eight different components: physical function;
physical role health; emotional role functions; vitality;
emotional wellbeing; social function; bodily pain; and general health perceptions. Each scale scored from 0 = least
favorable health state to 100 = most favorable health state.
The Arabic version of RAND-36 HRQoL was found to be
reliable [36]. More details of the study are discussed by
Ahmed et al. [36]. A total of 450 surveys were distributed
(81.3 % response rate), and 366 were returned.
Statistical analysis

The data analyses were conducted using IBM SPSS
Statistics (20; SPSS, Chicago, IL). Descriptive statistics
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were used to describe continuous and categorical variables (Table 1). We used negative binomial regression
model to identify the risk factors associated with the
high rate of SCD-related ED visits (Table 2). We
assessed the adequacy of multivariate regression model
by comparing the deviance and the log likelihood for
negative binomial and Poisson regression models. In all
analyses, P < 0.05 was considered significant.

Results
Of 366 patients, 58 (15.8 %) chose not to report their
SCD-related ED utilization within the past six months,
thus the self-report of SCD-related ED visits was completed by 308 SCD patients. Of the 308 SCD patients, only
21 (6.8 %) reported no SCD-related ED visits, 28 (9.1 %)
reported one SCD-related ED visit, and 61 (19.8 %) reported two SCD-related ED visits. The majority of our
samples, 198 (64.3 %), reported three or more SCDTable 1 Participant characteristics
Characteristics

Levels

Number

Percent

Age/year

Mean ± SD

29.0 ± 10.5

Number of SCD-related ED visits

Median(IQR)

4(2–7)

Female gender

No

273

74.6

Yes

93

25.4

No

269

74.5

Yes

92

25.5

No

164

45.6

Yes

196

54.4

No

124

36.6

Yes

215

63.4

No

232

64.3

Yes

129

35.7

No

296

90.8

Yes

30

9.2

No

186

51.4

Yes

176

48.6

No

242

67.0

Yes

119

33.0

No

219

60.5

Yes

143

39.5

No

97

26.6

Yes

267

73.4

No

28

7.7

Yes

335

92.3

No

39

11.0

Yes

317

89.0

No

303

84.4

Yes

56

15.6

University

Married

Unemployed

Regular exercise

Obese

Fever

Skin redness with itching

Swelling

Blood transfusion

Family history of anemia

Family support

Chronic disease other than SCD

related ED visits over the past 6 months (95 % confidence
limit: 58.7–69.6 %). The median number of SCD-related
ED visits was four (IQR 2–7) with ranges between 0 and
87 visits.
The SCD patients’ average age was 29 (SD = 10.5)
years, with 74.6 % being male and 35.7 % reporting regular exercise. Table 2 shows the factors associated with
the rate of SCD-related ED visits. Unadjusted analyses
show that the rate of SCD-related ED visits was higher
for the male gender (RR: 1.329 [95 % CI: 1.001–1.768,
P = 0.050]), married (RR: 1.413 [95 % CI: 1.106–1.804,
P = 0.006]), fever (RR: 1.460 [95 % CI: 1.146–1.860,
P = 0.002]), skin redness with itching (RR: 1.393
[95 % CI: 1.080–1.796, P = 0.011]), swelling (RR: 1.4 [95 %
CI: 1.094–1.792, P = 0.007]), blood transfusion (RR: 1.535
[95 % CI: 1.165–2.023, P = 0.002]), and older age
(RR: 1.013 [95 % CI: 1.001–1.025, P = 0.034]).
The rate of SCD-related ED visits was less for unemployed patients (RR: 0.745 [95 % CI: 0.577–0.962,
P = 0.024]). The rate of SCD-related ED visits decreased for every point increase in physical function
(RR: 0.993 [95 % CI: 0.988–0.998, P = 0.010]), physical
role functions (RR: 0.994 [95 % CI: 0.991–0.998, P = 0.001]),
emotional role functions (RR: 0.996 [95 % CI: 0.993–0.999,
P = 0.007]), vitality (RR: 0.988 [95 % CI: 0.981–0.995,
P = 0.001]), social function (RR: 0.991 [95 % CI:
0.986–0.996, P = 0.001]), and general health (RR: 0.982
[95 % CI: 0.975–0.989, P = 0.001]). The rate of SCDrelated ED visits decreased for every point decrease in
bodily pain (RR: 0.992 [95 % CI: 0.988–0.997, P = 0.001]).
Adjusted analysis in Table 2 shows the factors associated
with the high rate of SCD-related ED visits. According to
the multivariable negative binomial regression model, the
rate of SCD-related ED visits was much higher for those
with a university degree (RR: 1.502 [95 % CI: 1.050–2.149,
P = 0.026]). The rate of SCD-related ED visits decreased
for every point increase in general health (RR: 0.986 [95 %
CI: 0.975–0.998, P = 0.018]).
The deviance value for the negative binomial regression
model was near to1.0 (0.96), while for a Poisson regression
model was (6.937). The log likelihood was smaller for the
Poisson regression model compared to the negative binomial regression model ( −1066.150 vs. −644.880), which
indicates the negative binomial regression model may be
appropriate.

Discussion
This study represents the first investigation in the entire
Arabic world on SCD patients’ symptoms and QoL relative to the number of their SCD-related ED visits. We
found that the frequent SCD-related ED utilization (three
SCD-related ED visits or greater within a 6-month time
period) was very prevalent in the Saudi population, with
64.3 % (95 % confidence limit: 58.7–69.6 %). A small
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Table 2 Factors associated with the rate of SCD-related ED visits
Unadjusted model

Multivariate adjusted model
95 % Wald CI for RR

Male gender

95 % Wald CI for RR

B

P

RR

Lower

Upper

B

P

RR

Lower

Upper

.285

.050a

1.329

1.001

1.768

.137

.513

1.146

.762

1.725

a

University degree

.147

.298

1.159

.878

1.529

.407

.026

1.502

1.050

2.149

Married

.345

.006a

1.413

1.106

1.804

−.153

.456

.858

.574

1.283

Unemployed

−.294

.024a

.745

.577

.962

−.308

.114

.735

.502

1.077

Regular exercise

−.161

.212

.851

.660

1.096

−.259

.148

.772

.544

1.096

Obese

.182

.434

1.199

.761

1.889

.453

.136

1.573

.868

2.850

Fever

.378

.002a

1.460

1.146

1.860

.032

.852

1.032

.741

1.438

Skin redness with itching

.331

a

.011

1.393

1.080

1.796

.002

.993

1.002

.693

1.447

Swelling

.337

.007a

1.400

1.094

1.792

.134

.464

1.143

.799

1.635

Blood transfusion

.429

a

.002

1.535

1.165

2.023

.152

.407

1.164

.813

1.667

Family history of anemia

.294

.227

1.342

.833

2.161

−.012

.970

.988

.522

1.869

Family support

.337

.097

1.401

.941

2.085

.207

.408

1.230

.753

2.012

Chronic disease other than SCD

−.088

.617

.916

.650

1.291

−.248

.340

.781

.469

1.299

Age

.013

.034a

1.013

1.001

1.025

.001

.892

1.001

.982

1.022

Physical function

−.007

.010a

.993

.988

.998

.002

.721

1.002

.993

1.010

Physical role functions

−.006

.001a

.994

.991

.998

−.002

.601

.998

.993

1.004

Emotional role functions

−.004

.007a

.996

.993

.999

−.003

.153

.997

.993

1.001

Vitality

−.012

a

.001

.988

.981

.995

−.002

.708

.998

.987

1.009

Emotional well-being

−.005

.113

.995

.988

1.001

.002

.680

1.002

.991

1.013

Social function

−.009

a

.001

.991

.986

.996

−.002

.687

.998

.989

1.007

Bodily pain

−.008

.001a

.992

.988

.997

−.004

.281

.996

.988

1.004

General health

−.018

a

.989

−.014

.986

.975

.998

.001

.982

.975

a

.018

Significant at α = 0.05

a

number of sickle cell patients (28.9 %) reported between
one and two SCD-related ED visits within a 6-month time
period, while (6.8 %) reported no SCD-related ED visits.
Previous studies, which were based on a daily diary of ED
utilization for pain management and other related causes,
reported 15–35.5 % of the patients with SCD had three or
more ED visits per year [8, 37, 38]. The current investigation showed higher rates of ED utilization than what has
been reported in these studies.
A retrospective exploratory chart review study found
that SCD patients with multiple ED visits in the past
12 months reported significantly higher pain scores [39].
Given that the methodology of Marco CA et al. was different compared to that of the present study, our unadjusted analysis is in line with their findings that the rate
of SCD-related ED visits increased because of pain. A survey with similar methodology to our study was conducted
by the CDC National Center for Health Statistics, which
reported pain as the most common reason for the ED visit
[40]. Another prospective study reported nearly 37 % of
ED use was because of painful episodes [41].

A retrospective study suggested that poorer physical
HRQoL domains were significantly correlated to more
healthcare utilization events [42]. Our unadjusted analyses confirmed these findings: all dimensions of HRQoL
were found to be predictors of high rates of SCD-related
ED visits except emotional well-being. According to our
unadjusted analyses, patients with clinical symptoms
such as fever, skin redness with itching, swelling, or
blood transfusion tend to have high rates of SCD-related
ED visits. These findings are in agreement with Yusuf
HR et al. [40] and Koshy M et al. [41], which have cited
fever as a reason for ED visits in patients with SCD.
In the multivariate negative binomial regression
model, the rate of SCD-related ED visits (50.2 % were
higher for SCD patients with a university degree. Using
an increase in general health ratings by a score of 1, the
rate of SCD-related ED visits decreased by 1.4 %.
Several methodological limitations could narrow our interpretations: The study was based on a cross-sectional design, and therefore provides more data about association
than causation. ED utilization was based on self-reporting,
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not on a retrospective or prospective chart review for each
visit. Our sample recruited from SCD patients who attended an outpatient clinic for a follow-up visit, which may
not represent the entire SCD population. Some modifiable
factors were not taken into consideration, such as having a
hematologist, or struggling with financial or transportation
issues. Despite these limitations, this is the first study that
has reported the ED utilization in patients with SCD in the
entire Arab region. While our study highlights ED
utilization in SCD patients, and despite its limitations, this
is the first study to highlight predictors of ED visits among
the population of Saudi Arabian SCD patients. The findings that the level of educational attainment and poorer
general health are independent risk factors of SCD-related
ED visits can assist medical professionals in informing and
educating SCD patients about disease management.

Conclusions
Saudi patients with sickle cell disease reported a wide
range of SCD-related ED visits. It was estimated that six
of 10 SCD patients had at least three ED visits within
a 6-month period. Well education and poor general
health resulted in an increase in the rate of SCD-related
ED visits. These findings can contribute to medical practitioners’ ability to manage and educate patients with SCD.
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